David P. Bender, MD
Associate Professor
University of Iowa Hospitals and Clinics
200 Hawkins Drive
31506 PFP
Iowa City,
IA
USA
52242
Papers:
97 - Featured Poster
A phase II trial of intraperitoneal EGEN-001, an interleukin (IL)-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: a GOG study
139 - Scientific Plenary
Health-related quality of life associated with every-3-week paclitaxel vs dose-dense weekly paclitaxel in combination with carboplatin with or without bevacizumab for primary ovarian cancer: Gynecologic Oncology Group study 262
417 - Poster Session B
Weight-based chemotherapy dosing does not increase chemotherapy-related toxicity in obese gynecologic cancer patients